Healthcare provider profile · identity verified

Daniel Joseph Ripp, MD

Internal Medicine · GREEN BAY, WI · NPI 1346267929

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	654	208
Amlodipine Besylate	Amlodipine Besylate	523	165
Losartan Potassium	Losartan Potassium	471	142
Simvastatin	Simvastatin	400	122
Lisinopril	Lisinopril	399	133
Levothyroxine Sodium	Levothyroxine Sodium	386	112
Metoprolol Succinate	Metoprolol Succinate	351	107
Omeprazole	Omeprazole	349	118
Hydrochlorothiazide	Hydrochlorothiazide	324	103
Rosuvastatin Calcium	Rosuvastatin Calcium	239	69
Pantoprazole Sodium	Pantoprazole Sodium	197	58
Tamsulosin Hcl	Tamsulosin Hcl	172	55
Gabapentin	Gabapentin	162	61
Metformin Hcl Er	Metformin Hcl	160	53
Atenolol	Atenolol	159	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	156	48
Eliquis	Apixaban	153	39
Allopurinol	Allopurinol	146	42
Sertraline Hcl	Sertraline Hcl	144	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	137	49
Finasteride	Finasteride	135	41
Metformin Hcl	Metformin Hcl	132	41
Alendronate Sodium	Alendronate Sodium	129	41
Ezetimibe	Ezetimibe	123	35
Metoprolol Tartrate	Metoprolol Tartrate	121	43
Potassium Chloride	Potassium Chloride	118	46
Diclofenac Sodium	Diclofenac Sodium	113	40
Escitalopram Oxalate	Escitalopram Oxalate	110	38
Tramadol Hcl	Tramadol Hcl	108	42
Warfarin Sodium	Warfarin Sodium	108	19
Lovastatin	Lovastatin	107	35
Carvedilol	Carvedilol	106	27
Citalopram Hbr	Citalopram Hydrobromide	106	24
Donepezil Hcl	Donepezil Hcl	105	17
Glipizide Er	Glipizide	102	29
Furosemide	Furosemide	97	42
Duloxetine Hcl	Duloxetine Hcl	96	32
Albuterol Sulfate Hfa	Albuterol Sulfate	91	34
Pravastatin Sodium	Pravastatin Sodium	86	24
Fluoxetine Hcl	Fluoxetine Hcl	84	20
Glipizide	Glipizide	83	22
Jardiance	Empagliflozin	73	23
Meloxicam	Meloxicam	70	26
Buspirone Hcl	Buspirone Hcl	68	16
Fluticasone Propionate	Fluticasone Propionate	66	25
Trazodone Hcl	Trazodone Hcl	66	23
Doxazosin Mesylate	Doxazosin Mesylate	64	21
Pioglitazone Hcl	Pioglitazone Hcl	60	14
Oxybutynin Chloride Er	Oxybutynin Chloride	55	16
Bumetanide	Bumetanide	51	13
Venlafaxine Hcl Er	Venlafaxine Hcl	50	suppressed
Alprazolam	Alprazolam	49	24
Fenofibrate	Fenofibrate	46	15
Clopidogrel	Clopidogrel Bisulfate	44	15
Bupropion Xl	Bupropion Hcl	41	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	13
Propranolol Hcl	Propranolol Hcl	40	11
Triamcinolone Acetonide	Triamcinolone Acetonide	38	25
Lorazepam	Lorazepam	37	18
Mirtazapine	Mirtazapine	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	13
Baclofen	Baclofen	35	suppressed
Prednisone	Prednisone	35	17
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Repaglinide	Repaglinide	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Famotidine	Famotidine	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Myrbetriq	Mirabegron	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Ozempic	Semaglutide	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Estradiol	Estradiol	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Digoxin	Digoxin	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Trulance	Plecanatide	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Indapamide	Indapamide	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error